Sunday, May 15, 2011

Cell Biosciences receives three US patents

 Cell Biosciences, Inc. announced the issuance of three key patents by the United States Patent and Trademark Office, Patent Nos. 7,935,489, 7,935,308 and 7,935,479.

These patents address central aspects of Cell Biosciences' NanoPro Assay Technology. NanoPro assay systems utilize novel approaches to protein capture and detection to enable high-sensitivity measurement of specific proteins in complex biological samples. These patents each focus on the fundamental capture and detection methodologies at the core of NanoPro Assay Technology.

“We are extremely pleased by the issuance of these key patents,” commented Bob Gavin, vice president of Product Development at Cell Biosciences. “As we expand the NanoPro product line into new markets, a strong intellectual property position will become increasingly important.” 

Cell Biosciences is a private life sciences company focused on defining the future of protein analysis. The company develops instrumentation systems, software and assay products that help researchers better understand proteins for fundamental research, biotherapeutics production, biomarker discovery and personalized medicine.

Source: Pharmabiz

Comments

Name
URL
Email
Email address is not published
Remember Me
Comments

CAPTCHA Reload
Write the characters in the image above